Idarucizumab (Praxbind) for reversal of pradaxa prior to emergent repair of contained ruptured transverse arch aneurysm

Annals of Cardiac Anaesthesia

Volumn 20, Issue 3, 2017, Pages 369-371

  Belli, Erol ^a,b   Lee, Teng ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DABIGATRAN ETEXILATE; FRESH FROZEN PLASMA; HEMOGLOBIN; IDARUCIZUMAB; LABETALOL; MONOCLONAL ANTIBODY; NICARDIPINE; PROTAMINE SULFATE; ANTICOAGULANT AGENT; DABIGATRAN;

AGED; ANEURYSM RUPTURE; AORTIC CLAMPING; ARTERY CATHETERIZATION; ARTICLE; ASCENDING AORTA; ATRIAL FIBRILLATION; BLOOD CLOTTING DISORDER; BLOOD PRESSURE; BRAIN PERFUSION; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTAINED RUPTURED TRANSVERSE ARCH ANEURYSM; CRYOPRECIPITATE; DEEP HYPOTHERMIC CIRCULATORY ARREST; DESCENDING AORTA; DIAPHORESIS; DISEASE ASSOCIATION; DRUG ACTIVITY; ENDOVASCULAR ANEURYSM REPAIR; ERYTHROCYTE CONCENTRATE; FALSE ANEURYSM; FOREARM; HEART RIGHT ATRIUM; HEMATOMA; HEMOGLOBIN BLOOD LEVEL; HEPARINIZATION; HUMAN; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; MALE; MORNING DOSAGE; PARTIAL THROMBOPLASTIN TIME; PEROPERATIVE CARE; PLASMA TRANSFUSION; PLEURA EFFUSION; POSTOPERATIVE CARE; PROTHROMBIN TIME; SOFT TISSUE INJURY; STERNOTOMY; THORACIC AORTA ANEURYSM; THORAX PAIN; THROMBOCYTE TRANSFUSION; ANTAGONISTS AND INHIBITORS; BLOOD TRANSFUSION; BLOOD VESSEL TRANSPLANTATION; DIAGNOSTIC IMAGING; PROCEDURES; THORACIC AORTA; X-RAY COMPUTED TOMOGRAPHY;

AGED; ANEURYSM, RUPTURED; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTICOAGULANTS; AORTA, THORACIC; AORTIC ANEURYSM, THORACIC; BLOOD TRANSFUSION; BLOOD VESSEL PROSTHESIS IMPLANTATION; CARDIOPULMONARY BYPASS; DABIGATRAN; HUMANS; MALE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85025173979     PISSN: 09719784     EISSN: 09745181     Source Type: Journal    
DOI: 10.4103/0971-9784.210426     Document Type: Article

References (7)

1. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-51.
2. Honickel M, Braunschweig T, van Ryn J, Ten Cate H, Spronk HM, Rossaint R, et al. Prothrombin complex concentrate is effective in treating the anticoagulant effects of dabigatran in a porcine polytrauma model. Anesthesiology 2015;123:1350-61.
3. Wanek MR, Horn ET, Elapavaluru S, Baroody SC, Sokos G. Safe use of hemodialysis for dabigatran removal before cardiac surgery. Ann Pharmacother 2012;46:e21.
4. Warkentin TE, Margetts P, Connolly SJ, Lamy A, Ricci C, Eikelboom JW. Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding. Blood 2012;119:2172-4.
5. Fellner C. Pharmaceutical approval update. P T 2015;40:807-8.
6. Miyares MA, Kuyumjian Y, Eaves S, Dollard E. Idarucizumab, a humanized, monoclonal antibody fragment for immediate reversal of dabigatran. J Pharm Pract 2015;28:548-54.
7. Starke RM, Komotar RJ, Connolly ES. A prospective cohort study of idarucizumab for reversal of dabigatran-associated hemorrhage. Neurosurgery 2015;77:N11-3.